ArticleJournal of personalized medicine2021

Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide.

Fabiana Gregucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.